Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 573, Issue 1-3, Pages 214-215Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2007.07.012
Keywords
paracetamol; cannabinoid receptor; neuropathic pain
Categories
Ask authors/readers for more resources
Paracetamol analgesic mechanism of action is still poorly defined but mainly involves central inhibition of cyclooxygenases. Here we tested the peripheral antinociceptive effects of paraceramol (intraplantar injections) in a rat model of neuropathic pain. Paracetamol dose-dependently decreased mechanical allodynia and lowered nociceptive scores associated with hyperalgesia testing. These effects were inhibited by the administration of cannabinoid CB1 (AM251) and CB2 (AM630) receptor antagonists. The participation of the peripheral cannabinoid system in paracetamol analgesia is suggested. (c) 2007 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available